Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-5 of 5 for your search:
Drug:
DetoxPC
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Randomized Study Comparing Immunologic Responses of Stage II and III Colorectal Cancer Patients on Adjuvant Therapy Treated with 3H1 Anti-Idiotype Monoclonal Antibody Mixed with Sargramostim Versus 3H1 Anti-Idiotype Monoclonal Antibody Alum Precipitate Mixed with Sargramostim (Summary Last Modified 01/2000)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UKMC-95GI24CB
, NCI-H97-1184
2.
Phase II Study of Vaccine Therapy With Tumor-Specific Mutated Ras Peptides in Combination With Interleukin-2 and/or Sargramostim (GM-CSF) in Adults With Metastatic Solid Tumors
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-97-C-0141F
, NCI-T96-0078, T96-0078, NCT00019331
3.
Phase I Study of Carcinoembryonic Antigen Peptide-1 (CAP) and DetoxPC for Adenocarcinomas of the Gastrointestinal Tract, Breast, and Lung (Summary Last Modified 09/1999)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-96-C-0139
, NCI-NMOB-9305, NCI-T96-0058N, T96-0058
4.
Phase I Study of Recombinant Carcinoembryonic Antigen (CEA) Vaccinia Virus Vaccine With Post Vaccination CEA Peptide Challenge in Patients With Malignant Solid Tumors (Summary Last Modified 04/2000)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
over 18
Sponsor:
NCI
Protocol IDs:
MUSC-6124
, NCI-T95-0044, T95-0044
5.
Phase I Pilot Adjuvant Study of Immunological Parameters Associated With Skin Testing and Vaccination With Autologous Lung Tumor Associated Antigen Plus DetoxPC in Patients With Curatively Resected Stage I, II, or IIIA Non-Small Cell Lung Cancer or Stage I or II Mesothelioma (Summary Last Modified 08/1999)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
20 to 70
Sponsor:
NCI
Protocol IDs:
RPCI-DS-96-25
, NCI-G99-1551, NCT00003974
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute